NMOSD发作间期无症状脑病变发生率研究
该研究基于国家癌症中心NMOSD数据库,回顾性分析了145例AQP4抗体阳性患者在接受免疫抑制治疗后无复发期间的370次纵向脑MRI,评估发作间期新发无症状脑病变。结果显示仅5例(3.4%)出现新发无症状脑病变,均为小于6mm的非特异性深部白质病变,未见NMOSD特征性或钆增强病变,提示临床稳定期常规MRI罕有NMOSD特征性新发病变。
要点
- 免疫抑制治疗后无复发期AQP4抗体阳性NMOSD患者新发无症状脑病变罕见(3.4%)。
- 所有新发病变均小于6mm且为非特异性,未见NMOSD特征性或钆增强病变。
- 临床稳定期常规脑MRI对NMOSD疾病监测价值有限,不支持频繁筛查。
核心结论
- 免疫抑制治疗后临床稳定的AQP4抗体阳性NMOSD患者在无复发期常规MRI上罕有无症状脑病变。
- 无复发期未见NMOSD特征性脑病变或钆增强病变。
研究设计与样本
- 纳入标准为免疫抑制治疗后无复发期至少1年期间有纵向脑MRI,共370次纵向评估的脑MRI。
主要发现
- 145例中5例(3.4%)在总观察708人年的无复发期内检出新发无症状深部白质病变。
- 所有病变均小于6mm,评估为非特异性。
- 未发现NMOSD特征性脑病变或钆增强病变。
临床怎么用
- 临床稳定的AQP4抗体阳性NMOSD患者免疫抑制治疗后,常规脑MRI新发无症状病变罕见,可参考此结果优化影像监测策略。
局限性
- 回顾性研究设计。
- 仅分析常规MRI,未评估更敏感成像技术。
- 样本来自单中心数据库。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether aquaporin-4 (AQP4) antibody-seropositive patients with neuromyelitis optica spectrum disorder (NMOSD) develop new asymptomatic brain lesions during the interattack period. METHODS: Of 296 consecutive AQP4 antibody-seropositive patients in the NMOSD database of the National Cancer Center from May 2005 to November 2019, 145 patients, who had serial brain MRI scans over an interval of at least 1 year during relapse-free period after immunosuppressive therapy, with 370 longitudinally assessed brain MRI scans were included in this study. We retrospectively analyzed them for presence of new subclinical brain lesions during the relapse-free period. RESULTS: Five of 145 patients (3.4%) had detectable new, asymptomatic brain lesions in the deep white matter over a total observed relapse-free period of 708 person-years. All the lesions were smaller than 6 mm and assessed to be nonspecific. No brain lesion characteristic of NMOSD or gadolinium-enhancing lesion was identified. CONCLUSIONS: Asymptomatic brain lesions are rarely observed on conventional MRI in clinically stable AQP4 antibody-seropositive patients with NMOSD after immunosuppressive therapy and brain MRI lesions characteristic of NMOSD are not seen in the relapse-free period. These findings may provide further insight regarding currently known diagnostic and disease-monitoring strategies in NMOSD.
引用
- Lee MY, Yong KP, Hyun JW, et al. Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder. Neurology. 2020. PMID: 32928976. doi:10.1212/WNL.0000000000010847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。